Literature DB >> 28979948

Cell Therapy and Critical Limb Ischemia: Evidence and Window of Opportunity in Obesity.

Sally L Elshaer1, Renee E Lorys1, A B El-Remessy1.   

Abstract

Entities:  

Keywords:  Critical limb ischemia; Inflammation; Metabolic syndrome; Stem cell therapy

Year:  2016        PMID： 28979948      PMCID： PMC5624549          DOI： 10.15226/2374-8354/3/1/00121

Source DB:  PubMed          Journal:  Obes Control Ther        ISSN： 2374-8354


× No keyword cloud information.
  93 in total

Review 1.  The pathophysiology of the collateral circulation (arteriogenesis).

Authors:  I Buschmann; W Schaper
Journal:  J Pathol       Date:  2000-02       Impact factor: 7.996

2.  Therapeutic angiogenesis in patients with severe limb ischemia by transplantation of a combination stem cell product.

Authors:  Gabriel P Lasala; Jose A Silva; Jose J Minguell
Journal:  J Thorac Cardiovasc Surg       Date:  2011-11-12       Impact factor: 5.209

Review 3.  Mesenchymal stem cells: clinical applications and biological characterization.

Authors:  Frank P Barry; J Mary Murphy
Journal:  Int J Biochem Cell Biol       Date:  2004-04       Impact factor: 5.085

4.  Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).

Authors:  L Norgren; W R Hiatt; J A Dormandy; M R Nehler; K A Harris; F G R Fowkes
Journal:  J Vasc Surg       Date:  2007-01       Impact factor: 4.268

Review 5.  Vascular repair by endothelial progenitor cells.

Authors:  Anna Zampetaki; John Paul Kirton; Qingbo Xu
Journal:  Cardiovasc Res       Date:  2008-03-18       Impact factor: 10.787

6.  Endothelial progenitor cells in adolescents: impact of overweight, age, smoking, sport and cytokines in younger age.

Authors:  Christian Jung; Nicole Fischer; Michael Fritzenwanger; Hansjörg Thude; Markus Ferrari; Marlen Fabris; Bernhard R Brehm; Dagmar Barz; Hans R Figulla
Journal:  Clin Res Cardiol       Date:  2008-11-25       Impact factor: 5.460

7.  The effects of HMG-CoA reductase inhibitor on vascular progenitor cells.

Authors:  Takanori Kusuyama; Takashi Omura; Daisuke Nishiya; Soichiro Enomoto; Ryo Matsumoto; Takashi Murata; Kazuhide Takeuchi; Junichi Yoshikawa; Minoru Yoshiyama
Journal:  J Pharmacol Sci       Date:  2006-08-05       Impact factor: 3.337

8.  Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.

Authors:  Frédéric Deschaseaux; Zohair Selmani; Pierre-Emmanuel Falcoz; Nursen Mersin; Nicolas Meneveau; Alfred Penfornis; Colette Kleinclauss; Sidney Chocron; Joseph-Philippe Etievent; Pierre Tiberghien; Jean-Pierre Kantelip; Siamak Davani
Journal:  Eur J Pharmacol       Date:  2007-02-01       Impact factor: 4.432

9.  Autologous transplantation of peripheral blood endothelial progenitor cells (CD34+) for therapeutic angiogenesis in patients with critical limb ischemia.

Authors:  F A Kudo; T Nishibe; M Nishibe; K Yasuda
Journal:  Int Angiol       Date:  2003-12       Impact factor: 2.789

10.  Bone marrow alterations and lower endothelial progenitor cell numbers in critical limb ischemia patients.

Authors:  Martin Teraa; Ralf W Sprengers; Peter E Westerweel; Hendrik Gremmels; Marie-José T H Goumans; Tom Teerlink; Frans L Moll; Marianne C Verhaar
Journal:  PLoS One       Date:  2013-01-31       Impact factor: 3.240
View more
  1 in total

1.  miR-210 Enhances the Therapeutic Potential of Bone-Marrow-Derived Circulating Proangiogenic Cells in the Setting of Limb Ischemia.

Authors:  Marie Besnier; Stefano Gasparino; Rosa Vono; Elena Sangalli; Amanda Facoetti; Valentina Bollati; Laura Cantone; Germana Zaccagnini; Biagina Maimone; Paola Fuschi; Daniel Da Silva; Michele Schiavulli; Sezin Aday; Massimo Caputo; Paolo Madeddu; Costanza Emanueli; Fabio Martelli; Gaia Spinetti
Journal:  Mol Ther       Date:  2018-06-15       Impact factor: 11.454
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.